Specifically, Iba1-immunoreactive microglia are more commonly found in viable tumor areas, whereas CD163-expressing macrophages, likely of recent bone marrow origin, predominate in necrobiotic and necrotic tissue areas of glioblastoma [70]. The gene discussed is CD163; the disease is neoplasm.